Clean Diesel Technologies, Inc. (NASDAQ: CDTI) is a cleantech emissions control company that designs, develops and manufactures sustainable solutions to reduce emissions of on- and off-road engine applications. Within its sector, the company is a global manufacturer and distributor of … Continue reading →

Cipher Pharmaceuticals, Inc. (NASDAQ: CPHR) is a dermatology company committed to offering healthcare professionals products that will better address their patients’ needs and enrich their practices. As such, the company’s innovative dermatology products provide efficacy, flexibility and convenience across a … Continue reading →

China XD Plastics Company Ltd. (NASDAQ: CXDC) engages in researching, developing, manufacturing and selling modified plastics primarily for automotive applications in China and Dubai, the United Arab Emirates. The company’s modified plastics are used to fabricate various auto components, including … Continue reading →

China Recycling Energy Corp. (NASDAQ: CREG) designs, finances, constructs, operates and transfers waste energy recycling projects to mid- to large-size enterprises involved in high energy-consuming businesses. The company offers waste pressure to energy systems, including the blast furnace top gas … Continue reading →

China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD), through its own retail drugstores, wholesale distributor and online pharmacy, is a retailer and wholesale distributor of pharmaceutical and healthcare products in China. As of March 31, 2015, the company had 59 retail pharmacies … Continue reading →

China Energy Technology Corp., Ltd. (OTC: CETH) designs, manufactures, and sells solar water heaters and related solar products. The company offers vacuum tube solar energy collector, as well as the balcony flat panel solar energy collector type solar water heating … Continue reading →

ChemoCentryx, Inc. (NASDAQ: CCXI) is a biopharmaceutical company that specializes in creating orally administered new medicines that inhibit chemo-attractant receptors – the engines of cell migration in disease. The company focuses exclusively on discovering, developing and commercializing orally-administered therapeutics to … Continue reading →

Chembio Diagnostics, Inc. (NASDAQ: CEMI) is committed to delivering exceptional products that provide ease of use, and rapid and accurate results at the point-of-care (POC). At the core of its commitment is its patented Next Generation DPP (Dual Path Platform) … Continue reading →

Check-Cap Ltd. (NASDAQ: CHEK) is a clinical stage medical diagnostics company leading the development of the first ingestible imaging capsule that utilizes low-dose X-rays for CRC screening. The Check-Cap device requires no bowel preparation or invasive procedures, and is designed … Continue reading →

Cesca Therapeutics Inc. (NASDAQ: KOOL) is focused on three target markets: cellular therapeutics; medical/diagnostic device development and commercialization; and cell manufacturing and banking. Cesca’s lead therapeutic technology platform, SurgWerks (an intraoperative rapid system for harvesting, selection/purification, testing, and delivering a … Continue reading →